|
2023
|
Invention
|
Anti-axl antagonistic antibodies.
The present disclosure relates to antibodies that specifically... |
|
|
Invention
|
Anti-axl antagonistic antibodies.
Described are antibodies that specifically bind to the Axl pro... |
|
2021
|
Invention
|
Anti-axl antagonistic antibodies. The present disclosure relates to antibodies that specifically ... |
|
2020
|
Invention
|
System for charged particle therapy verification. A system for charged particle therapy verificat... |
|
2019
|
Invention
|
Large area microwave plasma cvd apparatus and corresponding method for providing such deposition.... |
|
|
Invention
|
Combination therapy including beta-sitosterol in combination with at least one of a braf inhibito... |
|
|
Invention
|
Antibody against alpha-11 integrin and its use. In a first aspect, the present invention relates ... |
|
2018
|
Invention
|
Inhibitors. The present invention relates to compounds having the formula [Co-enzyme A or analogu... |
|
|
Invention
|
Anti-axl antagonistic antibodies. Described are antibodies that specifically bind to the Axl prot... |
|
|
Invention
|
Method for producing an icing protected arrangement and icing protected arrangement. An Icing pro... |
|
|
Invention
|
Microstructured sapphire substrates. The present invention relates to sapphire substrates having ... |
|
|
Invention
|
Tissue engineering scaffolds. A scaffold (12) for tissue engineering comprises an inner portion (... |
|
2017
|
Invention
|
Methods using axl as a biomarker of epithelial-to-mesenchymal transition.
The present invention ... |
|
|
Invention
|
Neutral-beam microscopy. A method of designing a neutral-beam microscope (1) is disclosed. The ne... |
|
|
Invention
|
Novel immunotherapeutic treatments for tumours. The present invention provides a method for the t... |
|
|
Invention
|
Compounds for treating congenital disorders of glycosylation. The present invention relates to th... |
|
|
Invention
|
Process. The present invention relates to processes to make neosaxitoxin, and analogues and varia... |
|
2016
|
Invention
|
Process for hydrolysing fish bone, product therefrom and its use for improving flesh pigmentation... |
|
|
Invention
|
Wnt/beta-catenin signal transduction inhibitors and their use in treatment or prevention of disea... |
|
|
Invention
|
Hyperphenylalaninemia and treatments thereof. The present invention relates to compounds of formu... |
|
|
Invention
|
Method of predicting parameters of a geological formation. 3, . . . ) which give the mutual match... |
|
|
Invention
|
Method of predicting parameters of a geological formation. A method of predicting model parameter... |
|
|
Invention
|
Olefin metathesis catalysts. The present invention refers to novel ruthenium-based catalysts for ... |
|
|
Invention
|
Improved olefin metathesis catalysts. The present invention refers to novel ruthenium-based catal... |
|
|
Invention
|
Use of fgf19 to increase muscle fiber size. The present invention relates to an FGF19 polypeptide... |
|
|
Invention
|
Novel therapeutic use of fgf19. The present invention relates to a FGF19 polypeptide for its use ... |
|
|
Invention
|
Organometallic catalysts. The present invention refers to novel ruthenium- and osmium-based catal... |
|
2015
|
Invention
|
Cyclic phosphoric acid derivative for the treatment of chronic fatigue syndrome. The present inve... |
|
|
Invention
|
Method and apparatus for processing three-dimensional image data.
A method of processing three-d... |
|
|
Invention
|
Method and apparatus for processing three-dimensional image data. A method of processing three-di... |
|
2014
|
Invention
|
Activators or stimulators of soluble guanylate cyclase for use in treating chronic fatigue syndro... |
|
|
Invention
|
Phenazine derivatives as anti-neoplastic agents and anti-infective agents. Novel phenazine deriva... |
|
|
Invention
|
Phenazine derivatives as anti-cancer and anti-infective agents. The invention provides novel phen... |
|
|
Invention
|
Method of forming a desired pattern on a substrate.
The present invention relates to a method of... |
|
|
Invention
|
Natural lipids containing non-oxidizable fatty acids.
Provided herein is technology relating to ... |
|
|
Invention
|
Vaccine. E coli heat-stable toxin (ST) having the following wild-type sequence: NSSNYCCELCCNPACTG... |
